SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,093,000 | +16.1% | 26,024 | +0.8% | 0.87% | +11.9% |
| Q2 2020 | $4,386,000 | +44.6% | 25,813 | -1.8% | 0.77% | +23.8% |
| Q1 2020 | $3,034,000 | -0.3% | 26,297 | -1.3% | 0.62% | +24.5% |
| Q4 2019 | $3,043,000 | -2.9% | 26,630 | -27.5% | 0.50% | -2.9% |
| Q3 2019 | $3,135,000 | +21.7% | 36,706 | -1.3% | 0.52% | +21.4% |
| Q2 2019 | $2,575,000 | -6.3% | 37,197 | -0.9% | 0.43% | -10.1% |
| Q1 2019 | $2,748,000 | +32.3% | 37,529 | +2.4% | 0.47% | +18.5% |
| Q4 2018 | $2,077,000 | -29.5% | 36,657 | -4.0% | 0.40% | -19.0% |
| Q3 2018 | $2,946,000 | +14.8% | 38,203 | -1.2% | 0.49% | +11.0% |
| Q2 2018 | $2,567,000 | – | 38,655 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |